Viewing Study NCT03576612


Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2026-02-03 @ 5:05 AM
Study NCT ID: NCT03576612
Status: COMPLETED
Last Update Posted: 2025-02-14
First Post: 2018-05-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas
Sponsor: Candel Therapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioma, Malignant View
Keywords:

Keywords

Keyword Brief Keyword Text View
None glioblastoma, newly diagnosed, GMCI, Checkpoint inhibitor View